NIH-funded research R01 grant

Using nanobubbles to deliver oxygen during cardiac arrest and organ ischemia

Official title: Nanobubble oxygenation in cardiac arrest and acute vital organ ischemia

Funded at University of Minnesota · NIH-11076250 · Data updated 2026-11-12

This study is exploring a new way to deliver oxygen directly into the bloodstream using a special mixture of saline and oxygen, which could help people in emergencies like cardiac arrest by keeping their organs safe until more treatment can be given.

More Cardiac Arrest research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startApril 17, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$678,487
NIH project number5R01HL169329-02
Project IDNIH-11076250 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing cardiac arrest or severe oxygen deprivation, particularly in emergency medical situations.

Less likely to help

Patients who are not experiencing acute oxygen deprivation or cardiac events may not benefit from this research.

What this research studies

This research investigates a novel method of delivering oxygen directly into the bloodstream using a highly pressurized saline and oxygen mixture. By infusing this solution during critical situations like cardiac arrest, the goal is to improve oxygen levels in the blood, which can help protect vital organs from damage. The approach aims to sustain oxygen requirements for a short period, potentially buying time for more definitive medical interventions. This could be particularly beneficial in emergency settings where traditional oxygen delivery methods are not effective.

Why it matters

Potential benefit: If successful, this research could significantly improve survival rates and outcomes for patients experiencing cardiac arrest or acute organ ischemia.

How similar studies have gone: While the concept of direct intravenous gas delivery has been traditionally viewed as risky, this innovative approach is exploring untested methods that could lead to significant advancements in emergency care.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Yannopoulos, Demetris — University of Minnesota
  • Study coordinator: Yannopoulos, Demetris

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.